Prolonged reactivation of cytomegalovirus infection following successful rituximab therapy for Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder

Int J Hematol. 2007 Oct;86(3):291-2. doi: 10.1532/IJH97.07100.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anemia, Aplastic / blood
  • Anemia, Aplastic / complications
  • Anemia, Aplastic / therapy
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Bone Marrow Transplantation
  • Cytomegalovirus
  • Epstein-Barr Virus Infections / blood
  • Epstein-Barr Virus Infections / diagnostic imaging
  • Epstein-Barr Virus Infections / drug therapy*
  • Epstein-Barr Virus Infections / etiology
  • Female
  • Herpesvirus 4, Human* / physiology
  • Humans
  • Immunologic Factors / administration & dosage*
  • Lymphoproliferative Disorders / blood
  • Lymphoproliferative Disorders / diagnostic imaging
  • Lymphoproliferative Disorders / drug therapy*
  • Lymphoproliferative Disorders / etiology
  • Radiography
  • Rituximab
  • Time Factors
  • Virus Activation / drug effects*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab